SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-14-068922
Filing Date
2014-11-14
Accepted
2014-11-14 17:02:36
Documents
9
Period of Report
2014-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q v393420_10q.htm 10-Q 549288
2 EXHIBIT 31.1 v393420_ex31-1.htm EX-31.1 9013
3 EXHIBIT 32.1 v393420_ex32-1.htm EX-32.1 4259
  Complete submission text file 0001144204-14-068922.txt   7482509

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE DOCUMENT vgen-20140930.xml EX-101.INS 1410784
5 XBRL TAXONOMY EXTENSION SCHEMA vgen-20140930.xsd EX-101.SCH 49510
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE vgen-20140930_cal.xml EX-101.CAL 34674
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE vgen-20140930_def.xml EX-101.DEF 315913
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE vgen-20140930_lab.xml EX-101.LAB 338127
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vgen-20140930_pre.xml EX-101.PRE 367146
Mailing Address 5300 WESTVIEW DRIVE SUITE 406 FREDERICK MD 21703
Business Address 5300 WESTVIEW DRIVE SUITE 406 FREDERICK MD 21703 301-668-8400
VACCINOGEN INC (Filer) CIK: 0001453001 (see all company filings)

IRS No.: 000000000 | State of Incorp.: MD
Type: 10-Q | Act: 34 | File No.: 000-54997 | Film No.: 141225270
SIC: 2834 Pharmaceutical Preparations